MiR-26b-5p mediates radioresistance and immunosuppression via targeting PRKCD in non-small cell lung cancer. Chen X, Kong R, Qi Y, Li L, et al. J Cancer Res Clin Oncol 2025;151:262.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chen X, Kong R, Qi Y, Li L, et al. MiR-26b-5p mediates radioresistance and immunosuppression via targeting PRKCD in non-small cell lung cancer. J Cancer Res Clin Oncol 2025;151:262.
PMID: 40965741